These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2292114)

  • 1. Public health service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use.
    Can Dis Wkly Rep; 1990 Nov; 16 Suppl 2():4-13. PubMed ID: 2292114
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for counselling persons who have had an occupational exposure to human immunodeficiency virus.
    Elmslie K; Ricketts M; Mulligan L
    Can Dis Wkly Rep; 1990 Nov; 16 Suppl 2():1-3. PubMed ID: 2292113
    [No Abstract]   [Full Text] [Related]  

  • 3. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jun; 45(22):468-80. PubMed ID: 8622618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use.
    MMWR Recomm Rep; 1990 Jan; 39(RR-1):1-14. PubMed ID: 2105451
    [No Abstract]   [Full Text] [Related]  

  • 5. Postexposure use of zidovudine by health-care workers examined in Public Health Service statement.
    Clin Pharm; 1990 Jun; 9(6):403, 406. PubMed ID: 2364644
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommendations for occupational exposures to HIV.
    Paul SM; Jorden V; Costa SJ; Ziskin LZ
    N J Med; 1999 Jan; 96(1):41-6. PubMed ID: 9949657
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational transmission of human immunodeficiency virus.
    Polis MA
    Ear Nose Throat J; 1990 Jun; 69(6):401-5. PubMed ID: 2198159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medically compromised patients, Part II. Current trends in zidovudine chemoprophylaxis post HIV exposure.
    Mito RS; Wahlers M
    J Calif Dent Assoc; 1995 Nov; 23(11):27-31. PubMed ID: 9051999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive use of AZT in occupational HIV exposure].
    Petzoldt D
    Hautarzt; 1991 Feb; 42(2):61-2. PubMed ID: 2037490
    [No Abstract]   [Full Text] [Related]  

  • 11. Needle sticks & AIDS.
    Grieco M
    N Y J Dent; 1990; ():8. PubMed ID: 2330187
    [No Abstract]   [Full Text] [Related]  

  • 12. PHS issues statement on postexposure zidovudine use.
    Am Fam Physician; 1990 Apr; 41(4):1305, 1308-9. PubMed ID: 2321498
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of the Occupational Safety and Health Administration's bloodborne pathogen standard for the occupational health professional.
    Udasin IG; Gochfeld M
    J Occup Med; 1994 May; 36(5):548-55. PubMed ID: 8027880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks to health care workers from occupational exposure to hepatitis B virus, human immunodeficiency virus, and cytomegalovirus.
    Gerberding JL
    Infect Dis Clin North Am; 1989 Dec; 3(4):735-45. PubMed ID: 2556471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational exposure to blood and body fluids: new postexposure prophylaxis recommendations. United States Occupational Safety and Health Administration.
    Cuny E; Carpenter WM
    J Calif Dent Assoc; 1998 Apr; 26(4):261-7, 269-71. PubMed ID: 9709639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and management of occupational exposures to human immunodeficiency virus (HIV).
    Calfee DP
    Mt Sinai J Med; 2006 Oct; 73(6):852-6. PubMed ID: 17117310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine after occupational exposure to the human immunodeficiency virus.
    Rhame FS; Russell AL
    N Engl J Med; 1991 Jan; 324(4):266-7. PubMed ID: 1985250
    [No Abstract]   [Full Text] [Related]  

  • 18. [HIV occupational infections in gynecology: risk assessment, post-exposure management, and drug prophylaxis].
    Puro V; D'Ubaldo C; De Carli G; Petrosillo N; Ippolito G;
    Minerva Ginecol; 2000 Dec; 52(12 Suppl 1):25-33. PubMed ID: 11526686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-exposure HIV prevention within and outside the hospital].
    Jost J
    Ther Umsch; 1998 May; 55(5):289-94. PubMed ID: 9643126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postexposure protocol.
    Younai FS
    Dent Clin North Am; 1996 Apr; 40(2):457-86. PubMed ID: 8641532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.